4.5 Review

Positron emission tomography imaging in cardiovascular disease

期刊

HEART
卷 106, 期 22, 页码 1712-1718

出版社

BMJ PUBLISHING GROUP
DOI: 10.1136/heartjnl-2019-315183

关键词

-

资金

  1. Wellcome Trust Clinical Research Career Development Fellowship [211100/Z/18/Z]
  2. National Institute for Health Research (NIHR) Imperial Biomedical Research Centre (BRC)
  3. Cambridge British Heart Foundation (BHF) Centre for Research Excellence
  4. NIHR Cambridge BRC
  5. BHF
  6. Higher Education Funding Council for England
  7. Engineering and Physical Sciences Research Council
  8. Wellcome Trust
  9. Wellcome Trust [211100/Z/18/Z] Funding Source: Wellcome Trust
  10. EPSRC [EP/N014588/1] Funding Source: UKRI

向作者/读者索取更多资源

Positron emission tomography (PET) imaging is useful in cardiovascular disease across several areas, from assessment of myocardial perfusion and viability, to highlighting atherosclerotic plaque activity and measuring the extent of cardiac innervation in heart failure. Other important roles of PET have emerged in prosthetic valve endocarditis, implanted device infection, infiltrative cardiomyopathies, aortic stenosis and cardio-oncology. Advances in scanner technology, including hybrid PET/MRI and total body PET imaging, as well as the development of novel PET tracers and cardiac-specific postprocessing techniques using artificial intelligence will undoubtedly continue to progress the field.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据